FAKTOR RISIKO KEJADIAN PERTUSIS PADA BAYI DAN ANAK – ANAK (SISTEMATIK LITERATURE REVIEW)
DOI:
https://doi.org/10.51712/mitraraflesia.v16i2.394Abstract
ABSTRAK
Pendahuluan: Kebangkitan (resurgence) pertusis saat ini terjadi hampir di seluruh dunia dengan insiden tertinggi terjadi pada bayi dan menyebabkan kematian pada kasus pertusis berat. Kasus kematian yang terjadi umumnya ditemukan pada bayi berusia < 6 bulan akibat komplikasi pertusis. Tujuan dari penyusunan studi literature ini adalah untuk mempelajari tentang faktor risiko infeksi pertusis pada bayi dan anak-anak.
Metode : Metode yang digunakan yaitu studi literatur (literature review) Â yang disusun melalui penelusuran literatur terkait pertusis menggunakan metode PRISMA (Preferred Reporting Items for Systematic Reviews and Meta Analysis).
Hasil : Hasil menunjukkan bahwa faktor risiko pertusis pada bayi dan anak – anak dipengaruhi oleh usia, riwayat kontak dengan kasus pertusis, riwayat vaksinasi dan kualitas ventilasi udara yang buruk serta riwayat kelahiran premature dan berat badan lahir rendah (BBLR). Kesimpulan : Adanya faktor risiko pada kasus dugaan pertusis dapat bermanfaat untuk meningkatan kewaspadaan terhadap pertusis khususnya pada bayi dan anak – anak.
Keyword : Faktor Risiko, Pertussis, Bayi, Anak – Anak, Case Control
Â
ABSTRACT
Background : The resurgence of pertussis infection worldwide with he highest reported incidence occurred in infants that caused death on severe cases. A review about risk factor of pertussis are necessary, especially risk factor of pertussis on infants and children in low and middle-income country are poorly understood. This paper aimed to study about risk factors of pertussis infection among infants and children.
Methods : This paper used the systematic review. Articles are selected using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta Analysis).
Results : The results show that risk factor for pertussis in infants and children are infants < 3 months, household contacts, vaccination history and poor air ventilation, premature and low birth weight.
Conclusion : The findings indicated risk factor of pertussis may be useful for increasing awareness of pertussis among infants and children.
Keyword : Risk Factor,Pertussis,Infant, Children,Case Control
References
DAFTAR PUSTAKA
World Health Organization, WHO-recommendation standards for surveillance of selected vaccine-preventable-diseases. Geneva: World Health Organization, Department of Vaccines and Biologicals, 2008.
U. Thisyakorn, T. Tantawichien, C. Thisyakorn, and P. Buchy, “Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges,†International Journal of Infectious Diseases, vol. 87. Elsevier B.V., pp. 75–83, Oct. 01, 2019. doi: 10.1016/j.ijid.2019.07.016.
S. Matczak et al., “Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020,†Eurosurveillance, vol. 27, no. 25, Jun. 2022, doi: 10.2807/1560-7917.ES.2022.27.25.2100933.
R. Viswanathan et al., “Looking beyond Pertussis in Prolonged Cough Illness of Young Children,†Vaccines (Basel), vol. 10, no. 8, Aug. 2022, doi: 10.3390/vaccines10081191.
World Health Organization, Module-5 Pertussis. World Health Organization, 2018.
M. D. Decker and K. M. Edwards, “Pertussis (Whooping Cough),†Journal of Infectious Diseases, vol. 224, pp. S310–S320, Oct. 2021, doi: 10.1093/infdis/jiaa469.
S. G. Krishnan, W. H. Fun, M. D. Ramadras, R. Yunus, Y. F. Lye, and S. Sararaks, “Pertussis clinical case definition: Time for change in developing countries?,†PLoS One, vol. 14, no. 7, Jul. 2019, doi: 10.1371/journal.pone.0219534.
R. Muloiwa, F. S. Dube, M. P. Nicol, G. D. Hussey, and H. J. Zar, “Risk factors for Bordetella pertussis disease in hospitalized children,†PLoS One, vol. 15, no. 10 October, Oct. 2020, doi: 10.1371/journal.pone.0240717.
A. J. Chitkara et al., “Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative,†International Journal of Infectious Diseases, vol. 96. Elsevier B.V., pp. 482–488, Jul. 01, 2020. doi: 10.1016/j.ijid.2020.04.081.
E. Juscamayta-López, F. Valdivia, M. P. Soto, H. Horna, and M. Pajuelo, “Case-Control Study to Estimate the Association between Tdap Vaccination during Pregnancy and Reduced Risk of Pertussis in Newborn Infants in Peru, 2019-2021,†Open Forum Infect Dis, vol. 10, no. 7, Jul. 2023, doi: 10.1093/ofid/ofad325.
S. Ohfuji et al., “Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan,†Vaccine, vol. 39, no. 1, pp. 11–17, Jan. 2021, doi: 10.1016/j.vaccine.2020.11.035.
H. Kim et al., “Risk Factors of Pertussis Among Older Adults in South Korea: A Nationwide Health Data-Based Case–Control Study,†Infect Dis Ther, vol. 12, no. 2, pp. 545–561, Feb. 2023, doi: 10.1007/s40121-022-00747-0.
R. Solano, A. V. Sanchez-Callejas, M. I. Alvarez-Ibañez, M. Sandiumenge-Durán, and M. I. Fernández-San-MartÃn, “Proper pertussis vaccination will probably not increase vaccination coverage: A case–control study,†Epidemiol Infect, vol. 147, 2019, doi: 10.1017/S0950268819001444.
L. Almaw and H. Bizuneh, “Pertussis outbreak investigation in janamora district, amhara regional state, ethiopia: A case-control study,†Pan African Medical Journal, vol. 34, 2019, doi: 10.11604/pamj.2019.34.65.19612.
C. Liu, L. Yang, Y. Cheng, H. Xu, and F. Xu, “Risk factors associated with death in infants <120 days old with severe pertussis: a case-control study,†BMC Infect Dis, vol. 20, no. 1, Dec. 2020, doi: 10.1186/s12879-020-05535-0.
L. D. Frenkel, “The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?,†Allergy and Asthma Proceedings, vol. 42, no. 5. OceanSide Publications Inc., pp. 378–385, Sep. 01, 2021. doi: 10.2500/aap.2021.42.210065.
P. Kramarz, P. L. Lopalco, E. Huitric, and L. Pastore Celentano, “Vaccine-preventable diseases: The role of the European Centre for Disease Prevention and Control,†Clinical Microbiology and Infection, vol. 20, no. S5. Blackwell Publishing Ltd, pp. 2–6, 2014. doi: 10.1111/1469-0691.12430.
S. Son et al., “Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents,†Clinical Microbiology and Infection, vol. 25, no. 2, pp. 250.e1-250.e7, Feb. 2019, doi: 10.1016/j.cmi.2018.04.013.
S. Sapuan et al., “An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England,†Vaccine, vol. 40, no. 49, pp. 7050–7056, Nov. 2022, doi: 10.1016/j.vaccine.2022.10.005.
Centers for Disease Control, “Pertussis vaccination : Use of Ap vaccines among infants and young infants and young children recommendations of the advisory committee on immunization practices (ACIP),†cdc.gov/mmwr/preview/mmwrhtml/00048610
J. Mansor, H. Ismail, and N. Ismail, “Determinants of pertussis among young children in selangor, malaysia,†Sains Malays, vol. 50, no. 2, pp. 437–447, Feb. 2021, doi: 10.17576/jsm-2021-5002-15.
M. Z. Dudley et al., “Factors associated with referring close contacts to an app with individually-tailored vaccine information,†Vaccine, vol. 38, no. 13, pp. 2827–2832, Mar. 2020, doi: 10.1016/j.vaccine.2020.02.019.
S. Sunarno et al., “Laboratory and epidemiology data of pertussis cases and close contacts: A 5-year case-based surveillance of pertussis in Indonesia, 2016–2020,†PLoS One, vol. 17, no. 4 April, Apr. 2022, doi: 10.1371/journal.pone.0266033.
K. van Zoonen, W. L. M. Ruijs, H. E. De Melker, M. E. J. Bongers, and L. Mollema, “How to increase awareness of additional vaccinations; the case of maternal pertussis vaccination,†BMC Public Health, vol. 21, no. 1, p. 1257, Jun. 2021, doi: 10.1186/s12889-021-11344-0.
A. Kılıç et al., “The impact of early postpartum maternal pertussis vaccination on the protection of infants: A randomized clinical trial,†Iranian Journal of Immunology, vol. 16, no. 3, pp. 225–234, Jun. 2019, doi: 10.22034/iji.2019.80273.
F. Martinón-Torres et al., “Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial,†Vaccine, vol. 39, no. 11, pp. 1598–1608, Mar. 2021, doi: 10.1016/j.vaccine.2021.02.001.
N. A. T. Van Der Maas, E. A. M. Sanders, F. G. A. Versteegh, A. Baauw, A. Westerhof, and H. E. De Melker, “Pertussis hospitalizations among term and preterm infants: Clinical course and vaccine effectiveness,†BMC Infect Dis, vol. 19, no. 1, Oct. 2019, doi: 10.1186/s12879-019-4563-5.
(Print)
(Online)
